Cardio Diagnostics Hldgs Bolsa (NASDAQ: CDIO)

Últimas noticias sobre Cardio Diagnostics Hldgs (NASDAQ:CDIO) Bolsa

Cardio Diagnostics Hldgs

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ANAB

ASST

CCLD

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

DWTX

HSDT

HUBC

LSTA

NEHC

NFLX

SEPN

STFS

USEG

Netflix sorprende con un aumento en suscriptores y mejores pronósticos. Descubre también los mayores ganadores y perdedores del premercado.

Acciones de Netflix se disparan alrededor del 15%; 20 acciones que se están moviendo en el premercado de EE.UU.

JMP Securities analyst Devin Ryan maintains Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) with a Market Outperform and raises the price target from $125 to $130.

Price Target

Analyst Ratings

HOOD

JMP Securities Maintains Market Outperform on Robinhood Markets, Raises Price Target to $130

Events

JP Morgan Chase & Co. CEO Jamie Dimon To Appear Live On CNBC

Church &amp; Dwight Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHD#NYSE">CHD</a>) is gearing up to announce its quarterly earnings on Friday, 2025-08-01. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Church &amp; Dwight Co will report an earnings per share (EPS) of $0.85.
Anticipation surrounds Church &amp; Dwight Co's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
Last quarter the company beat EPS by $0.01, which was followed by a 0.61% increase in the share price the next day.
Here's a look at Church &amp; Dwight Co's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.90</td>
<td>0.77</td>
<td>0.68</td>
<td>0.84</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.91</td>
<td>0.77</td>
<td>0.79</td>
<td>0.93</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>5.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753974164_0.png" alt="eps graph" />
<h3>Performance of Church &amp; Dwight Co Shares</h3>
Shares of Church &amp; Dwight Co were trading at $95.95 as of July 30. Over the last 52-week period, shares are down 3.53%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Views on Church &amp; Dwight Co</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Church &amp; Dwight Co.
A total of 10 analyst ratings have been received for Church &amp; Dwight Co, with the consensus rating being Neutral. The average one-year price target stands at $102.0, suggesting a potential 6.31% upside.
<h3>Comparing Ratings with Peers</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of Kimberly-Clark, Reynolds Consumer Prods and WD-40, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Kimberly-Clark, with an average 1-year price target of $135.5, suggesting a potential 41.22% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Reynolds Consumer Prods, with an average 1-year price target of $23.0, suggesting a potential 76.03% downside.</li>
<li>Analysts currently favor an Buy trajectory for WD-40, with an average 1-year price target of $300.0, suggesting a potential 212.66% upside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
The peer analysis summary outlines pivotal metrics for Kimberly-Clark, Reynolds Consumer Prods and WD-40, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Church &amp; Dwight Co</td>
<td>Neutral</td>
<td>-2.41%</td>
<td>$659.60M</td>
<td>4.94%</td>
</tr>
<tr>
<td>Kimberly-Clark</td>
<td>Neutral</td>
<td>-6.00%</td>
<td>$1.73B</td>
<td>58.42%</td>
</tr>
<tr>
<td>Reynolds Consumer Prods</td>
<td>Neutral</td>
<td>-1.80%</td>
<td>$189M</td>
<td>1.45%</td>
</tr>
<tr>
<td>WD-40</td>
<td>Buy</td>
<td>1.21%</td>
<td>$88.11M</td>
<td>8.38%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Church &amp; Dwight Co ranks in the middle among its peers for Consensus rating. It ranks at the bottom for Revenue Growth. It is at the top for Gross Profit. It is at the bottom for Return on Equity.
<h3>Unveiling the Story Behind Church &amp; Dwight Co</h3>
Church &amp; Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm &amp; Hammer brand. Its mix also includes Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which together with Arm &amp; Hammer constitute around 70% of its annual sales and profits. Most recently, the firm announced the addition of Touchland, and its hand santizer business, to its fold. Even as it works to grow the reach of its products, Church &amp; Dwight still derives around 80% of its sales from its home market in the US.
<h3>Unraveling the Financial Story of Church &amp; Dwight Co</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Decline in Revenue: Over the 3 months period, Church &amp; Dwight Co faced challenges, resulting in a decline of approximately -2.41% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Church &amp; Dwight Co's net margin excels beyond industry benchmarks, reaching 15.0%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 4.94%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.47%, the company showcases effective utilization of assets.
Debt Management: Church &amp; Dwight Co's debt-to-equity ratio is below the industry average. With a ratio of 0.48, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/CHD/earnings">To track all earnings releases for Church &amp; Dwight Co visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

An Overview of Church & Dwight Co's Earnings

Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) is preparing to release its quarterly earnings on Friday, 2025-08-01. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Kimberly-Clark to report an earnings per share (EPS) of $1.67.
Anticipation surrounds Kimberly-Clark's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.04, leading to a 3.28% drop in the share price on the subsequent day.
Here's a look at Kimberly-Clark's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.89</td>
<td>1.51</td>
<td>1.70</td>
<td>1.71</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.93</td>
<td>1.50</td>
<td>1.83</td>
<td>1.96</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.0%</td>
<td>0.0%</td>
<td>-1.0%</td>
<td>3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753974154_0.png" alt="eps graph" />
<h3>Kimberly-Clark Share Price Analysis</h3>
Shares of Kimberly-Clark were trading at $125.29 as of July 30. Over the last 52-week period, shares are down 10.46%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Analyst Insights on Kimberly-Clark</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Kimberly-Clark.
A total of 4 analyst ratings have been received for Kimberly-Clark, with the consensus rating being Neutral. The average one-year price target stands at $135.5, suggesting a potential 8.15% upside.
<h3>Peer Ratings Comparison</h3>
The below comparison of the analyst ratings and average 1-year price targets of Church &amp; Dwight Co, Colgate-Palmolive and Reynolds Consumer Prods, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Church &amp; Dwight Co, with an average 1-year price target of $102.0, suggesting a potential 18.59% downside.</li>
<li>Analysts currently favor an Buy trajectory for Colgate-Palmolive, with an average 1-year price target of $97.33, suggesting a potential 22.32% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Reynolds Consumer Prods, with an average 1-year price target of $23.0, suggesting a potential 81.64% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
The peer analysis summary presents essential metrics for Church &amp; Dwight Co, Colgate-Palmolive and Reynolds Consumer Prods, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kimberly-Clark</td>
<td>Neutral</td>
<td>-6.00%</td>
<td>$1.73B</td>
<td>58.42%</td>
</tr>
<tr>
<td>Church &amp; Dwight Co</td>
<td>Neutral</td>
<td>-2.41%</td>
<td>$659.60M</td>
<td>4.94%</td>
</tr>
<tr>
<td>Colgate-Palmolive</td>
<td>Buy</td>
<td>-3.04%</td>
<td>$2.99B</td>
<td>240.00%</td>
</tr>
<tr>
<td>Reynolds Consumer Prods</td>
<td>Neutral</td>
<td>-1.80%</td>
<td>$189M</td>
<td>1.45%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Kimberly-Clark ranks in the middle for consensus rating. It is at the bottom for revenue growth. It is at the top for gross profit. It is at the top for return on equity.
<h3>Discovering Kimberly-Clark: A Closer Look</h3>
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
<h3>Kimberly-Clark's Financial Performance</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Kimberly-Clark faced challenges, resulting in a decline of approximately -6.0% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Kimberly-Clark's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 11.71% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Kimberly-Clark's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 58.42% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Kimberly-Clark's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 3.45%, the company showcases efficient use of assets and strong financial health.
Debt Management: Kimberly-Clark's debt-to-equity ratio surpasses industry norms, standing at 6.58. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<a href="https://www.benzinga.com/quote/KMB/earnings">To track all earnings releases for Kimberly-Clark visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Examining the Future: Kimberly-Clark's Earnings Outlook

RBC Bearings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBC#NYSE">RBC</a>) is gearing up to announce its quarterly earnings on Friday, 2025-08-01. Here's a quick overview of what investors should know before the release.
Analysts are estimating that RBC Bearings will report an earnings per share (EPS) of $2.67.
The announcement from RBC Bearings is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company beat EPS by $0.13, leading to a 0.0% drop in the share price the following trading session.
Here's a look at RBC Bearings's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2025</th>
<th>Q3 2025</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.70</td>
<td>2.20</td>
<td>2.30</td>
<td>2.39</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.83</td>
<td>2.34</td>
<td>2.29</td>
<td>2.54</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>8.0%</td>
<td>2.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753974143_0.png" alt="eps graph" />
<h3>RBC Bearings Share Price Analysis</h3>
Shares of RBC Bearings were trading at $384.87 as of July 30. Over the last 52-week period, shares are up 39.9%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analysts' Take on RBC Bearings</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on RBC Bearings.
The consensus rating for RBC Bearings is Buy, based on 5 analyst ratings. With an average one-year price target of $423.4, there's a potential 10.01% upside.
<h3>Analyzing Ratings Among Peers</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Nordson, IDEX and Lincoln Electric Holdings, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Nordson, with an average 1-year price target of $251.67, suggesting a potential 34.61% downside.</li>
<li>Analysts currently favor an Buy trajectory for IDEX, with an average 1-year price target of $216.4, suggesting a potential 43.77% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Lincoln Electric Holdings, with an average 1-year price target of $222.0, suggesting a potential 42.32% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
In the peer analysis summary, key metrics for Nordson, IDEX and Lincoln Electric Holdings are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>RBC Bearings</td>
<td>Buy</td>
<td>5.80%</td>
<td>$193.40M</td>
<td>2.44%</td>
</tr>
<tr>
<td>Nordson</td>
<td>Outperform</td>
<td>4.96%</td>
<td>$373.90M</td>
<td>3.85%</td>
</tr>
<tr>
<td>IDEX</td>
<td>Buy</td>
<td>1.72%</td>
<td>$368.90M</td>
<td>2.48%</td>
</tr>
<tr>
<td>Lincoln Electric Holdings</td>
<td>Neutral</td>
<td>2.36%</td>
<td>$365.45M</td>
<td>8.88%</td>
</tr>
</tbody>
</table>

Key Takeaway:
RBC Bearings ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.
<h3>Unveiling the Story Behind RBC Bearings</h3>
RBC Bearings Inc is an international manufacturer and marketer of engineered precision bearings, components, and essential systems for the industrial, defense, and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The company has two reportable segments: Industrial, which derives maximum revenue, and Aerospace/Defense. The Aerospace/Defense segment represents the end markets for the company's engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and the Industrial segment represents the end markets for its products used in various industrial applications. Geographically, the company generates a majority of its revenue from the United States.
<h3>RBC Bearings: Delving into Financials</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: RBC Bearings displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 5.8%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: RBC Bearings's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 16.61%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): RBC Bearings's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.44%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 1.55%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: RBC Bearings's debt-to-equity ratio is below the industry average. With a ratio of 0.34, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/RBC/earnings">To track all earnings releases for RBC Bearings visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights Ahead: RBC Bearings's Quarterly Earnings

Insider buying has been remarkably scarce in recent months. Top executives across corporate America appear hesitant to commit their own capital in the open market. This reluctance can be attributed to a mix of uncertainty around fiscal policy, questions about the Federal Reserve's next steps on interest rates, and persistent concerns about valuation levels in a market that remains near its highs. Historically, insider buying has been a reliable signal of confidence. When it dries up, it often reflects caution in the C‑suite. That is why the few purchases we have seen recently deserve attention.
Last week, two such transactions stood out not just for their size, but for their rarity. Henry Fernandez, the long‑time Chairman and CEO of MSCI Inc. (Ticker: MSCI) made a substantial purchase of his company's stock. At the same time, Yogesh Gupta, CEO of Progress Software, and independent director David Krall, both stepped into the market to add to their stakes. These are not routine transactions. They are meaningful signals in an environment otherwise defined by insider silence.
Henry Fernandez's purchase was particularly notable. On July 24 and 25, he acquired 12,400 shares of MSCI at prices between $535 and $550, committing roughly $6.7 million of his own money. This was the largest insider purchase at MSCI in at least a year and raised his direct ownership to approximately 1.28 million shares.
MSCI is a company with an enviable position in the financial world. Its index division provides the benchmarks for trillions of dollars in exchange‑traded funds and institutional portfolios. Whenever money flows into an MSCI‑tracked ETF, the firm collects a slice. This high‑margin, fee‑based model produces a steady and predictable revenue stream. Beyond its index business, MSCI offers a robust analytics platform, ESG and climate data solutions, and real estate analytics through its private assets segment. In effect, MSCI has become the backbone of many institutional investment processes, collecting recurring revenue from some of the largest asset managers in the world.
The company's second quarter results, released July 22, underscore why Fernandez might be confident. MSCI reported $772.7 million in revenue, up 9 percent from the prior year, with earnings per share of $4.17, a figure that exceeded Wall Street estimates. Its net margin remained near 40 percent, a level that few firms can match. Return on equity hovered above 20 percent, reflecting both profitability and efficient capital use. Analysts, for their part, continue to assign price targets clustered around $650 to $680, suggesting meaningful upside from the current price of roughly $560.
From a valuation perspective, MSCI trades at about 36 times earnings, a premium multiple that reflects the company's dominant competitive position, high switching costs for clients, and durable revenue growth. While not cheap by traditional metrics, Fernandez's multimillion‑dollar purchase indicates he views today's valuation as attractive relative to the company's long‑term prospects.
The other notable activity came from Progress Software, a mid‑cap technology firm with a market capitalization of roughly $2.2 billion. On July 23, CEO Yogesh Gupta purchased 2,100 shares at about $49 per share, committing just over $103,000. On the same day, independent director David Krall made a larger buy of 5,125 shares at roughly $48.90, spending around $250,600. Krall's purchase marked the largest insider buy at Progress Software in more than a year, increasing his stake by roughly 11 percent.
Progress Software occupies a specialized but vital niche in enterprise technology. The company's platforms and tools help businesses modernize legacy systems, develop and deploy applications, manage secure data transfers, and monitor digital experiences. Its suite includes widely used products such as OpenEdge, MOVEit, Sitefinity, WhatsUp Gold, and Kemp LoadMaster. These offerings have become critical for organizations undergoing digital transformation, especially in sectors where reliability and security are paramount.
Recent financial results have been encouraging. In its most recent quarter, Progress reported $152.6 million in revenue, up nearly 40 percent year over year, and earnings per share of $1.18, which exceeded analyst expectations. Management also raised full‑year guidance, reflecting confidence in continued growth. The company has pursued strategic acquisitions, including Kemp Technologies, to broaden its reach in application delivery and load balancing.
What makes the Gupta and Krall purchases particularly significant is the broader backdrop. Over the past six months, insider activity at Progress had leaned heavily toward selling, with executives such as the CFO and CIO reducing their positions. Against that trend, the CEO and a long‑time director have stepped in as buyers. Analysts are also constructive, with DA Davidson and Wedbush assigning "Buy" or "Outperform" ratings and setting price targets around $75. Guggenheim has gone further, projecting a target in the low $80s. At current levels around $50, that implies substantial potential upside.
From a valuation standpoint, Progress trades at around 37 to 38 times trailing earnings, though forward multiples drop closer to 28 times as projected earnings growth kicks in. While insider ownership remains modest at roughly 1.1 percent of outstanding shares, these recent purchases highlight management's confidence in the company's trajectory.
When insider buying dries up, investors should pay attention to the exceptions. Fernandez's $6.7 million purchase at MSCI and the coordinated Gupta‑Krall buys at Progress Software are exactly that—exceptions worth noting. Both companies operate in sectors with high switching costs, recurring revenues, and durable demand. Both have delivered strong recent results, and both face bright growth prospects.
In an environment where most insiders remain cautious, these transactions stand out as expressions of conviction. They may not guarantee short‑term gains, but they do signal that two experienced management teams see value in their businesses even as the broader market treads carefully.
For investors looking for cues amid the noise, these are rare signals worth watching.

Opinion

MSCI

Alpha Buying: Two Quiet Buys Could Be the Loudest Market Signal Yet

nVent Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVT#NYSE">NVT</a>) is set to give its latest quarterly earnings report on Friday, 2025-08-01. Here's what investors need to know before the announcement.
Analysts estimate that nVent Electric will report an earnings per share (EPS) of $0.79. 
The market awaits nVent Electric's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.01, which was followed by a 0.0% drop in the share price the next day.
Here's a look at nVent Electric's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.66</td>
<td>0.59</td>
<td>0.77</td>
<td>0.82</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.67</td>
<td>0.59</td>
<td>0.84</td>
<td>0.82</td>
</tr>
<tr>
<td>Price Change %</td>
<td>6.0%</td>
<td>3.0%</td>
<td>-8.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753974133_0.png" alt="eps graph" />
<h3>Performance of nVent Electric Shares</h3>
Shares of nVent Electric were trading at $78.72 as of July 30. Over the last 52-week period, shares are up 23.7%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Observations about nVent Electric</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on nVent Electric.
With 9 analyst ratings, nVent Electric has a consensus rating of Outperform. The average one-year price target is $79.67, indicating a potential 1.21% upside.
<h3>Understanding Analyst Ratings Among Peers</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Generac Hldgs, Regal Rexnord and Acuity, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Generac Hldgs, with an average 1-year price target of $176.75, suggesting a potential 124.53% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Regal Rexnord, with an average 1-year price target of $168.86, suggesting a potential 114.51% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Acuity, with an average 1-year price target of $324.0, suggesting a potential 311.59% upside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
The peer analysis summary outlines pivotal metrics for Generac Hldgs, Regal Rexnord and Acuity, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>nVent Electric</td>
<td>Outperform</td>
<td>10.54%</td>
<td>$313.70M</td>
<td>10.53%</td>
</tr>
<tr>
<td>Generac Hldgs</td>
<td>Buy</td>
<td>5.94%</td>
<td>$371.99M</td>
<td>1.77%</td>
</tr>
<tr>
<td>Regal Rexnord</td>
<td>Outperform</td>
<td>-8.37%</td>
<td>$527.60M</td>
<td>0.90%</td>
</tr>
<tr>
<td>Acuity</td>
<td>Neutral</td>
<td>21.74%</td>
<td>$570.20M</td>
<td>3.86%</td>
</tr>
</tbody>
</table>

Key Takeaway:
nVent Electric ranks top in Revenue Growth among its peers. It ranks bottom in Gross Profit and Return on Equity.
<h3>Unveiling the Story Behind nVent Electric</h3>
nVent is a leading global provider of electrical connection and protection solutions that touches a broad range of end markets including infrastructure, industrial, commercial, and residential. NVent designs, manufacturers, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.
<h3>nVent Electric's Economic Impact: An Analysis</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: nVent Electric's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 10.54%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: nVent Electric's net margin excels beyond industry benchmarks, reaching 44.57%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 10.53%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 5.36%, the company showcases effective utilization of assets.
Debt Management: nVent Electric's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.52.
<a href="https://www.benzinga.com/quote/NVT/earnings">To track all earnings releases for nVent Electric visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What to Expect from nVent Electric's Earnings

JMP Securities analyst Andrew Boone maintains Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) with a Market Outperform and raises the price target from $440 to $460.

CVNA

JMP Securities Maintains Market Outperform on Carvana, Raises Price Target to $460

Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) is preparing to release its quarterly earnings on Friday, 2025-08-01. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Moderna to report an earnings per share (EPS) of $-2.98.
Investors in Moderna are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings History Snapshot</h3>
The company's EPS beat by $0.66 in the last quarter, leading to a 2.15% increase in the share price on the following day.
Here's a look at Moderna's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-3.18</td>
<td>-2.68</td>
<td>-1.90</td>
<td>-3.39</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-2.52</td>
<td>-2.91</td>
<td>0.03</td>
<td>-3.33</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>3.0%</td>
<td>-7.000000000000001%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753974123_0.png" alt="eps graph" />
<h3>Moderna Share Price Analysis</h3>
Shares of Moderna were trading at $32.15 as of July 30. Over the last 52-week period, shares are down 64.15%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Analysts' Take on Moderna</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Moderna.
Analysts have given Moderna a total of 6 ratings, with the consensus rating being Neutral. The average one-year price target is $36.83, indicating a potential 14.56% upside.
<h3>Peer Ratings Overview</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of United Therapeutics, BioMarin Pharmaceutical and Neurocrine Biosciences, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for United Therapeutics, with an average 1-year price target of $369.71, suggesting a potential 1049.95% upside.</li>
<li>Analysts currently favor an Outperform trajectory for BioMarin Pharmaceutical, with an average 1-year price target of $97.75, suggesting a potential 204.04% upside.</li>
<li>Analysts currently favor an Buy trajectory for Neurocrine Biosciences, with an average 1-year price target of $154.29, suggesting a potential 379.91% upside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
Within the peer analysis summary, vital metrics for United Therapeutics, BioMarin Pharmaceutical and Neurocrine Biosciences are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Moderna</td>
<td>Neutral</td>
<td>-35.93%</td>
<td>$17M</td>
<td>-9.26%</td>
</tr>
<tr>
<td>United Therapeutics</td>
<td>Buy</td>
<td>17.22%</td>
<td>$701.90M</td>
<td>4.86%</td>
</tr>
<tr>
<td>BioMarin Pharmaceutical</td>
<td>Outperform</td>
<td>14.84%</td>
<td>$593.59M</td>
<td>3.24%</td>
</tr>
<tr>
<td>Neurocrine Biosciences</td>
<td>Buy</td>
<td>11.12%</td>
<td>$563.40M</td>
<td>0.31%</td>
</tr>
</tbody>
</table>

Key Takeaway:
In terms of consensus rating, Moderna is rated lower than the top peer and higher than the bottom peer. Moderna has the lowest revenue growth among its peers. Moderna's gross profit is the lowest among its peers. Moderna's return on equity is also the lowest among its peers.
<h3>Delving into Moderna's Background</h3>
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
<h3>Financial Insights: Moderna</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Moderna's financials over 3 months reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -35.93% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Moderna's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -907.48%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Moderna's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -9.26%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Moderna's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -7.23%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.07.
<a href="https://www.benzinga.com/quote/MRNA/earnings">To track all earnings releases for Moderna visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MRNA

Moderna's Earnings: A Preview

A substantial insider sell was reported on July 31, by Randall K Fields, Chief Executive Officer at ReposiTrak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRAK#NYSE">TRAK</a>), based on the recent SEC filing.
What Happened: Fields opted to sell 7,500 shares of ReposiTrak, according to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000050471/000141588925020659//Archives/edgar/data/50471/000141588925020659/0001415889-25-020659-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The transaction's total worth stands at $132,635.
As of Thursday morning, ReposiTrak shares are down by 0.0%, currently priced at $16.81.
<h3>About ReposiTrak</h3>
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.
<h3>A Deep Dive into ReposiTrak's Financials</h3>
Revenue Growth: Over the 3 months period, ReposiTrak showcased positive performance, achieving a revenue growth rate of 16.3% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 84.58%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, ReposiTrak exhibits below-average bottom-line performance with a current EPS of 0.1.
</li>
</ul>
Debt Management: ReposiTrak's debt-to-equity ratio is below the industry average at 0.02, reflecting a lower dependency on debt financing and a more conservative financial approach.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a higher-than-average P/E ratio of 49.44, ReposiTrak's stock is perceived as being overvalued in the market.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 14.59 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): A high EV/EBITDA ratio of 32.46 reflects market recognition of ReposiTrak's value, positioning it as more highly valued compared to industry peers.
</li>
</ul>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
Insider transactions, although significant, should be considered within the larger context of market analysis and trends.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000050471">Check Out The Full List Of ReposiTrak's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

TRAK

Chief Executive Officer Of ReposiTrak Makes $132K Sale

Investors with a lot of money to spend have taken a bullish stance on Caterpillar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CAT, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Caterpillar.
This isn't normal.
The overall sentiment of these big-money traders is split between 60% bullish and 20%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $247,900, and 9 are calls, for a total amount of $741,185.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $320.0 to $470.0 for Caterpillar during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Caterpillar options trades today is 523.54 with a total volume of 420.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Caterpillar's big money trades within a strike price range of $320.0 to $470.0 over the last 30 days.
<h3>Caterpillar 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753974113_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/29/25</td>
<td>$43.45</td>
<td>$42.35</td>
<td>$42.93</td>
<td>$400.00</td>
<td>$214.8K</td>
<td align="right">84</td>
<td align="right">50</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/29/25</td>
<td>$42.15</td>
<td>$40.35</td>
<td>$41.85</td>
<td>$400.00</td>
<td>$208.9K</td>
<td align="right">84</td>
<td align="right">50</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$54.6</td>
<td>$54.05</td>
<td>$54.05</td>
<td>$400.00</td>
<td>$81.0K</td>
<td align="right">448</td>
<td align="right">15</td>
</tr>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$6.25</td>
<td>$5.95</td>
<td>$5.95</td>
<td>$425.00</td>
<td>$59.5K</td>
<td align="right">453</td>
<td align="right">102</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$30.1</td>
<td>$28.9</td>
<td>$29.6</td>
<td>$450.00</td>
<td>$59.2K</td>
<td align="right">738</td>
<td align="right">5</td>
</tr>
</tbody>
</table>

<h3>About Caterpillar</h3>
Caterpillar is the world's leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines and diesel-electric locomotives. Its reporting segments are: construction industries (40% sales/47% operating profit, or OP), resource industries (20% sales/19% OP), and energy &amp; transportation (40% sales/34% OP). Market share approaches 20% across many products. Caterpillar operates a captive finance subsidiary to facilitate sales. The firm has global reach (46% US sales/54% ex-US). Construction skews more domestic, while the other divisions are more geographically diversified. An independent network of 156 dealers operates approximately 2,800 facilities, giving Caterpillar reach into about 190 countries for sales and support services.
Following our analysis of the options activities associated with Caterpillar, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Caterpillar</h3>
<ul>
<li>With a trading volume of 574,482, the price of CAT is up by 1.24%, reaching $439.51.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 5 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Caterpillar</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $445.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Caterpillar, targeting a price of $383. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Caterpillar, which currently sits at a price target of $475. 
&#x2A; An analyst from Oppenheimer persists with their Outperform rating on Caterpillar, maintaining a target price of $483. 
&#x2A; An analyst from DA Davidson persists with their Neutral rating on Caterpillar, maintaining a target price of $388. 
&#x2A; In a positive move, an analyst from Melius Research has upgraded their rating to Buy and adjusted the price target to $500. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Caterpillar with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Spotlight on Caterpillar: Analyzing the Surge in Options Activity

Dominion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>) will release its quarterly earnings report on Friday, 2025-08-01. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Dominion Energy to report an earnings per share (EPS) of $0.68.
Dominion Energy bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Performance in Previous Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.18, leading to a 0.31% increase in the share price on the subsequent day.
Here's a look at Dominion Energy's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.75</td>
<td>0.55</td>
<td>0.93</td>
<td>0.59</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.93</td>
<td>0.58</td>
<td>0.98</td>
<td>0.65</td>
</tr>
<tr>
<td>Price Change %</td>
<td>0.0%</td>
<td>1.0%</td>
<td>-1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753974112_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Dominion Energy were trading at $58.25 as of July 30. Over the last 52-week period, shares are up 3.62%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analysts' Take on Dominion Energy</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Dominion Energy.
A total of 3 analyst ratings have been received for Dominion Energy, with the consensus rating being Neutral. The average one-year price target stands at $59.33, suggesting a potential 1.85% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Sempra, Public Service Enterprise and Consolidated Edison, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Sempra, with an average 1-year price target of $81.75, suggesting a potential 40.34% upside.</li>
<li>Analysts currently favor an Buy trajectory for Public Service Enterprise, with an average 1-year price target of $94.5, suggesting a potential 62.23% upside.</li>
<li>Analysts currently favor an Underperform trajectory for Consolidated Edison, with an average 1-year price target of $99.22, suggesting a potential 70.33% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
Within the peer analysis summary, vital metrics for Sempra, Public Service Enterprise and Consolidated Edison are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dominion Energy</td>
<td>Neutral</td>
<td>12.22%</td>
<td>$2.06B</td>
<td>2.42%</td>
</tr>
<tr>
<td>Sempra</td>
<td>Outperform</td>
<td>4.45%</td>
<td>$1.79B</td>
<td>2.97%</td>
</tr>
<tr>
<td>Public Service Enterprise</td>
<td>Buy</td>
<td>16.74%</td>
<td>$1.12B</td>
<td>3.88%</td>
</tr>
<tr>
<td>Consolidated Edison</td>
<td>Underperform</td>
<td>12.10%</td>
<td>$2.64B</td>
<td>3.46%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Dominion Energy ranks in the middle for revenue growth among its peers. It has the highest gross profit compared to its peers. In terms of return on equity, Dominion Energy is at the bottom among its peers.
<h3>Discovering Dominion Energy: A Closer Look</h3>
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion is constructing a rate-regulated 5.2 GW wind farm off the Virginia Beach coast.
<h3>Dominion Energy: Delving into Financials</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Positive Revenue Trend: Examining Dominion Energy's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 12.22% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Utilities sector.
Net Margin: Dominion Energy's net margin excels beyond industry benchmarks, reaching 15.6%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Dominion Energy's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.42%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Dominion Energy's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.61%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.67.
<a href="https://www.benzinga.com/quote/D/earnings">To track all earnings releases for Dominion Energy visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of Dominion Energy's Earnings

Revealing a significant insider sell on July 31, Williamson Laura B, President at Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>), as per the latest SEC filing.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000940944/000122520825006898//Archives/edgar/data/940944/000122520825006898/0001225208-25-006898-index.htm">U.S. Securities and Exchange Commission</a> on Thursday outlined that B executed a sale of 1,680 shares of Darden Restaurants with a total value of $343,867.
Monitoring the market, Darden Restaurants's shares down by 0.7% at $201.78 during Thursday's morning.
<h3>About Darden Restaurants</h3>
Darden Restaurants is the largest restaurant operator in the US full-service space, with consolidated revenue of $12.1 billion in fiscal 2025. The company maintains a portfolio of 11 restaurant brands: Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Ruth's Chris, Yard House, The Capital Grille, Seasons 52, Eddie V's, Bahama Breeze, The Capital Burger, and most recently, Chuy's. Darden generates revenue almost exclusively from company-owned restaurants, though a small network of franchised restaurants and consumer-packaged goods sales through the traditional grocery channel contribute modestly. As of the end of its fiscal 2025, the company operated 2,159 restaurants in the US.
<h3>Darden Restaurants's Economic Impact: An Analysis</h3>
Revenue Growth: Over the 3 months period, Darden Restaurants showcased positive performance, achieving a revenue growth rate of 10.63% as of 31 May, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 23.38%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 2.59, Darden Restaurants showcases strong earnings per share.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 2.7, Darden Restaurants adopts a prudent financial strategy, indicating a balanced approach to debt management.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: Darden Restaurants's P/E ratio of 22.88 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 1.99, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 15.82 is below the industry average, indicating that it may be relatively undervalued compared to peers.
</li>
</ul>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
Insider transactions serve as a piece of the puzzle in investment decisions, rather than the entire picture.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Navigating the World of Insider Transaction Codes</h3>
In the domain of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000940944">Check Out The Full List Of Darden Restaurants's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Williamson Laura B Implements A Sell Strategy: Offloads $343K In Darden Restaurants Stock

Whales with a lot of money to spend have taken a noticeably bearish stance on Oscar Health.
Looking at options history for Oscar Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 22% of the investors opened trades with bullish expectations and 77% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $397,999 and 7, calls, for a total amount of $232,000.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.0 to $25.0 for Oscar Health over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Oscar Health options trades today is 6952.33 with a total volume of 5,870.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Oscar Health's big money trades within a strike price range of $10.0 to $25.0 over the last 30 days.
<h3>Oscar Health Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753974107_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OSCR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.15</td>
<td>$1.05</td>
<td>$1.14</td>
<td>$10.00</td>
<td>$353.3K</td>
<td>5.7K</td>
<td>3.2K</td>
</tr>
<tr>
<td>OSCR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/01/25</td>
<td>$1.85</td>
<td>$1.7</td>
<td>$1.81</td>
<td>$16.00</td>
<td>$44.5K</td>
<td>5.2K</td>
<td>403</td>
</tr>
<tr>
<td>OSCR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$7.8</td>
<td>$7.6</td>
<td>$7.6</td>
<td>$10.00</td>
<td>$38.0K</td>
<td>4.3K</td>
<td>0</td>
</tr>
<tr>
<td>OSCR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$1.7</td>
<td>$1.65</td>
<td>$1.65</td>
<td>$15.00</td>
<td>$33.0K</td>
<td>9.3K</td>
<td>105</td>
</tr>
<tr>
<td>OSCR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$1.65</td>
<td>$1.6</td>
<td>$1.65</td>
<td>$15.00</td>
<td>$33.0K</td>
<td>9.3K</td>
<td>512</td>
</tr>
</tbody>
</table>

<h3>About Oscar Health</h3>
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
Following our analysis of the options activities associated with Oscar Health, we pivot to a closer look at the company's own performance.
<h3>Where Is Oscar Health Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 6,781,936, the OSCR's price is up by 3.36%, now at $14.47. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 6 days.</li>
</ul>
<h3>What The Experts Say On Oscar Health</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $12.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo downgraded its action to Underweight with a price target of $10. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Underweight rating for Oscar Health, targeting a price of $11. 
&#x2A; In a cautious move, an analyst from Barclays downgraded its rating to Underweight, setting a price target of $17. 
&#x2A; In a cautious move, an analyst from UBS downgraded its rating to Sell, setting a price target of $11. 
&#x2A; Reflecting concerns, an analyst from Baird lowers its rating to Neutral with a new price target of $14.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Oscar Health, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

OSCR

Market Whales and Their Recent Bets on OSCR Options

RAYMOND SCOTT, President and CEO at Lear (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>), reported an insider sell on July 31, according to a new SEC filing. 
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000842162/000095017025100610//Archives/edgar/data/842162/000095017025100610/0000950170-25-100610-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that SCOTT sold 5,000 shares of Lear. The total transaction amounted to $483,873. 
As of Thursday morning, Lear shares are down by 0.0%, currently priced at $94.26.
<h3>Delving into Lear's Background</h3>
Lear Corp designs, develops, and manufactures automotive seating and electrical systems and components. The company has two reporting segments Seating and E-Systems. Seating components include frames and mechanisms, covers (leather and woven fabric), seat heating and cooling, foam, and headrests. Automotive electrical distribution and connection systems and electronic systems include wiring harnesses, terminals and connectors, on-board battery chargers, high-voltage battery management systems. The company earns majority of its revenue from the seating segment.
<h3>A Deep Dive into Lear's Financials</h3>
Revenue Growth: Lear's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2025, the company experienced a revenue decline of approximately -47.97%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 7.28%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Lear's EPS outshines the industry average, indicating a strong bottom-line trend with a current EPS of 3.07.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.55, Lear adopts a prudent financial strategy, indicating a balanced approach to debt management.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 13.33 is lower than the industry average, implying a discounted valuation for Lear's stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 0.31 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry averages at 5.48, Lear could be considered undervalued.
</li>
</ul>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Insider transactions, although significant, should be considered within the larger context of market analysis and trends.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Important Transaction Codes</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000842162">Check Out The Full List Of Lear's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RAYMOND SCOTT Executes Sell Order: Offloads $483K In Lear Stock

Investors with a lot of money to spend have taken a bearish stance on Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TGT, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Target.
This isn't normal.
The overall sentiment of these big-money traders is split between 22% bullish and 55%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $87,120, and 6 are calls, for a total amount of $314,285.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $80.0 to $112.0 for Target over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Target's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Target's substantial trades, within a strike price spectrum from $80.0 to $112.0 over the preceding 30 days.
<h3>Target Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753974102_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$20.75</td>
<td>$20.5</td>
<td>$20.5</td>
<td>$95.00</td>
<td>$104.5K</td>
<td>801</td>
<td>67</td>
</tr>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$22.85</td>
<td>$22.0</td>
<td>$22.0</td>
<td>$80.00</td>
<td>$77.0K</td>
<td>276</td>
<td>0</td>
</tr>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/08/25</td>
<td>$0.95</td>
<td>$0.88</td>
<td>$0.95</td>
<td>$105.00</td>
<td>$42.4K</td>
<td>427</td>
<td>1.0K</td>
</tr>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$16.8</td>
<td>$16.4</td>
<td>$16.4</td>
<td>$90.00</td>
<td>$32.8K</td>
<td>1.0K</td>
<td>0</td>
</tr>
<tr>
<td>TGT</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/08/25</td>
<td>$10.25</td>
<td>$9.7</td>
<td>$10.0</td>
<td>$112.00</td>
<td>$30.0K</td>
<td>75</td>
<td>71</td>
</tr>
</tbody>
</table>

<h3>About Target</h3>
Target serves as the nation's seventh-largest retailer, with its strategy predicated on delivering a gratifying in-store shopping experience and a wide product assortment of trendy apparel, home goods, and household essentials at competitive prices. Target's upscale and stylish image began to carry national merit in the 1990s—a decade in which the brand saw its top line grow threefold to almost $30 billion—and has since cemented itself as a leading US retailer.Today, Target operates over 1,900 stores in the United States, generates over $100 billion in sales, and fulfills over 2 billion customer orders annually. The firm's vast footprint is concentrated in urban and suburban markets as the firm seeks to appeal to a more affluent consumer base.
Having examined the options trading patterns of Target, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Target Standing Right Now?</h3>
<ul>
<li>With a volume of 839,299, the price of TGT is down -1.11% at $102.0. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 20 days.</li>
</ul>
<h3>Professional Analyst Ratings for Target</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $91.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Barclays downgraded its rating to Underweight, setting a price target of $91. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Target, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

What the Options Market Tells Us About Target

Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) is preparing to release its quarterly earnings on Friday, 2025-08-01. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Ares Management to report an earnings per share (EPS) of $1.10.
Investors in Ares Management are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat EPS by $0.15, which was followed by a 0.7% drop in the share price the next day.
Here's a look at Ares Management's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.94</td>
<td>1.30</td>
<td>0.94</td>
<td>0.99</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.09</td>
<td>1.23</td>
<td>0.95</td>
<td>0.99</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>1.0%</td>
<td>-3.0%</td>
<td>-7.000000000000001%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753974100_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Ares Management were trading at $187.73 as of July 30. Over the last 52-week period, shares are up 34.81%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Views on Ares Management</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Ares Management.
Analysts have given Ares Management a total of 7 ratings, with the consensus rating being Outperform. The average one-year price target is $190.71, indicating a potential 1.59% upside.
<h3>Analyzing Ratings Among Peers</h3>
The below comparison of the analyst ratings and average 1-year price targets of T. Rowe Price Group, Franklin Resources and Blue Owl Capital, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for T. Rowe Price Group, with an average 1-year price target of $97.67, suggesting a potential 47.97% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Franklin Resources, with an average 1-year price target of $22.25, suggesting a potential 88.15% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Blue Owl Capital, with an average 1-year price target of $22.5, suggesting a potential 88.01% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
The peer analysis summary outlines pivotal metrics for T. Rowe Price Group, Franklin Resources and Blue Owl Capital, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ares Management</td>
<td>Outperform</td>
<td>53.92%</td>
<td>$431.68M</td>
<td>0.86%</td>
</tr>
<tr>
<td>T. Rowe Price Group</td>
<td>Neutral</td>
<td>0.78%</td>
<td>$922M</td>
<td>4.61%</td>
</tr>
<tr>
<td>Franklin Resources</td>
<td>Neutral</td>
<td>-1.92%</td>
<td>$1.67B</td>
<td>1.11%</td>
</tr>
<tr>
<td>Blue Owl Capital</td>
<td>Outperform</td>
<td>33.14%</td>
<td>$357.55M</td>
<td>0.33%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Ares Management ranks at the top for Revenue Growth with 53.92%, outperforming its peers. It is at the bottom for Gross Profit at $431.68M. Ares Management is at the bottom for Return on Equity with 0.86%.
<h3>Delving into Ares Management's Background</h3>
Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets, Secondaries Group, and Others. Its Credit Group generates maximum revenue and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate &amp; infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure, &amp; credit.
<h3>Breaking Down Ares Management's Financial Performance</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Ares Management's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 53.92%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Ares Management's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 2.01%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Ares Management's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 0.86%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Ares Management's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.08%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 4.46, Ares Management faces challenges in effectively managing its debt levels, indicating potential financial strain.
<a href="https://www.benzinga.com/quote/ARES/earnings">To track all earnings releases for Ares Management visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARES

Exploring Ares Management's Earnings Expectations

A significant insider transaction involving the exercise of company stock options was reported on July 30, by Kevin J Wheeler, Executive Chairman at A.O. Smith (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOS#NYSE">AOS</a>), as per the latest SEC filing.
What Happened: Wheeler, Executive Chairman at A.O. Smith, made a strategic move by exercising stock options for 22,200 shares of AOS as detailed in a Form 4 filing on Wednesday with the <a href="https://www.sec.gov/Archives/edgar/data/0000091142/000009114225000105//Archives/edgar/data/91142/000009114225000105/0000091142-25-000105-index.htm">U.S. Securities and Exchange Commission</a>. The transaction value amounted to $842,934.
During Thursday's morning session, A.O. Smith shares down by 1.68%, currently priced at $69.64. Considering the current price, Wheeler's 22,200 shares have a total value of $842,934.
<h3>Delving into A.O. Smith's Background</h3>
A.O. Smith manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments: North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for the residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s. However, the firm announced a strategic review of its China operations.
<h3>A Deep Dive into A.O. Smith's Financials</h3>
Revenue Growth: A.O. Smith's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2025, the company experienced a revenue decline of approximately -1.27%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: With a high gross margin of 39.27%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): A.O. Smith's EPS is below the industry average. The company faced challenges with a current EPS of 1.07. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: A.O. Smith's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.18.
Insights into Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 19.73 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 2.71 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): A.O. Smith's EV/EBITDA ratio, lower than industry averages at 12.98, indicates attractively priced shares.
</li>
</ul>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision. 
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Exploring Key Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000091142">Check Out The Full List Of A.O. Smith's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Executive Chairman At A.O. Smith Exercises Options Worth $842K

Highlighted on July 30, it was unveiled in an SEC filing that Trecker, Senior Vice President at Visteon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VC#NASDAQ">VC</a>), executed a significant transaction involving the exercise of company stock options.
What Happened: A notable Form 4 filing on Wednesday with the <a href="https://www.sec.gov/Archives/edgar/data/0001111335/000111133525000156//Archives/edgar/data/1111335/000111133525000156/0001111335-25-000156-index.htm">U.S. Securities and Exchange Commission</a> revealed that Trecker, Senior Vice President at Visteon, exercised stock options for 1,500 shares of VC, resulting in a transaction value of $67,094.
Visteon shares are currently trading down by 0.0%, with a current price of $111.71 as of Thursday morning. This brings the total value of Trecker's 1,500 shares to $67,094.
<h3>Discovering Visteon: A Closer Look</h3>
Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.
<h3>Financial Milestones: Visteon's Journey</h3>
Negative Revenue Trend: Examining Visteon's financials over 3 months reveals challenges. As of 30 June, 2025, the company experienced a decline of approximately -4.44% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 14.55%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 2.38, Visteon showcases strong earnings per share.
</li>
</ul>
Debt Management: Visteon's debt-to-equity ratio is below the industry average. With a ratio of 0.31, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Evaluating Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 10.64 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 0.81 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 6.37, Visteon's EV/EBITDA ratio reflects a below-par valuation compared to industry averages signalling undervaluation
</li>
</ul>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Exploring the Significance of Insider Trading</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>The Insider's Guide to Important Transaction Codes</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001111335">Check Out The Full List Of Visteon's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Major Exercise Alert: Kristin Trecker Exercises Options Worth $67K At Visteon

Magna International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGA#NYSE">MGA</a>) is set to give its latest quarterly earnings report on Friday, 2025-08-01. Here's what investors need to know before the announcement.
Analysts estimate that Magna International will report an earnings per share (EPS) of $1.17. 
Anticipation surrounds Magna International's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
During the last quarter, the company reported an EPS missed by $0.08, leading to a 0.0% drop in the share price on the subsequent day.
Here's a look at Magna International's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.86</td>
<td>1.52</td>
<td>1.41</td>
<td>1.44</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.78</td>
<td>1.69</td>
<td>1.28</td>
<td>1.35</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-6.0%</td>
<td>-5.0%</td>
<td>6.0%</td>
<td>-6.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1753974085_0.png" alt="eps graph" />
<h3>Performance of Magna International Shares</h3>
Shares of Magna International were trading at $40.79 as of July 30. Over the last 52-week period, shares are up 1.36%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MGA/earnings">To track all earnings releases for Magna International visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: Magna International's Earnings Preview

Press Releases

Trump's "Stargate AI" Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO

Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology

Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease

Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

BIAF

CSDX

INBS

SOBR

TRIB

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Alzamend Neuro

Apollomics Inc. - Class A Ordinary Shares

Apollomics

Aptevo Therapeutics

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Genprex

GT Biopharma

IN8bio

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Mustang Bio

Mainz Biomed

Palisade Bio

Polyrizon

PharmaCyte Biotech

Sunshine Biopharma

Silexion Therapeutics Corp - Ordinary Shares

Comments

Cardio Diagnostics Hldgs

Noticias

Últimas noticias sobre Cardio Diagnostics Hldgs (NASDAQ:CDIO) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL